FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008617110> ?p ?o ?g. }

• W2008617110 abstract "Antivirals play a critical role in the prevention and the management of influenza. One class of antivirals, neuraminidase inhibitors (NAIs), is effective against all human influenza viruses. Currently there are two NAI drugs which are licensed worldwide: oseltamivir (Tamiflu®) and zanamivir (Relenza®); and two drugs which have received recent approval in Japan: peramivir and laninamivir. Until recently, the prevalence of antiviral resistance has been relatively low. However, almost all seasonal H1N1 strains that circulated in 2008-09 were resistant to oseltamivir whereas about 1% of tested 2009 pandemic H1N1 viruses were found to be resistant to oseltamivir. To date, no studies have demonstrated widespread resistance to zanamivir. It seems likely that the literature on antiviral resistance associated with oseltamivir as well as zanamivir is now sufficiently comprehensive to warrant a systematic review.The primary objectives were to systematically review the literature to determine the incidence of resistance to oseltamivir, zanamivir, and peramivir in different population groups as well as assess the clinical consequences of antiviral resistance.We searched MEDLINE and EMBASE without language restrictions in September 2010 to identify studies reporting incidence of resistance to oseltamivir, zanamivir, and peramivir. We used forest plots and meta-analysis of incidence of antiviral resistance associated with the three NAIs. Subgroup analyses were done across a number of population groups. Meta-analysis was also performed to evaluate associations between antiviral resistance and clinical complications and symptoms.We identified 19 studies reporting incidence of antiviral resistance. Meta-analysis of 15 studies yielded a pooled incidence rate for oseltamivir resistance of 2.6% (95%CI 0.7% to 5.5%). The incidence rate for all zanamivir resistance studies was 0%. Only one study measured incidence of antiviral resistance among subjects given peramivir and was reported to be 0%. Subgroup analyses detected higher incidence rates among influenza A patients, especially for H1N1 subtype influenza. Considerable heterogeneity between studies precluded definite inferences about subgroup results for immunocompromised patients, in-patients, and children. A meta-analysis of 4 studies reporting association between oseltamivir-resistance and pneumonia yielded a statistically significant risk ratio of 4.2 (95% CI 1.3 to 13.1, p = 0.02). Oseltamivir-resistance was not statistically significantly associated with other clinical complications and symptoms.Our results demonstrate that that a substantial number of patients may become oseltamivir-resistant as a result of oseltamivir use, and that oseltamivir resistance may be significantly associated with pneumonia. In contrast, zanamivir resistance has been rarely reported to date." @default.
• W2008617110 created "2016-06-24" @default.
• W2008617110 creator A5001585828 @default.
• W2008617110 creator A5005935743 @default.
• W2008617110 creator A5008177827 @default.
• W2008617110 creator A5029801001 @default.
• W2008617110 date "2011-05-19" @default.
• W2008617110 modified "2023-10-17" @default.
• W2008617110 title "Systematic review of influenza resistance to the neuraminidase inhibitors" @default.
• W2008617110 cites W124634905 @default.
• W2008617110 cites W1896756572 @default.
• W2008617110 cites W1965226808 @default.
• W2008617110 cites W1975842996 @default.
• W2008617110 cites W1977401490 @default.
• W2008617110 cites W1981737639 @default.
• W2008617110 cites W1983060565 @default.
• W2008617110 cites W1990198260 @default.
• W2008617110 cites W1990858284 @default.
• W2008617110 cites W1992351879 @default.
• W2008617110 cites W1992738726 @default.
• W2008617110 cites W2003823802 @default.
• W2008617110 cites W200761781 @default.
• W2008617110 cites W2010284659 @default.
• W2008617110 cites W2020100779 @default.
• W2008617110 cites W2026984266 @default.
• W2008617110 cites W2030323841 @default.
• W2008617110 cites W2030678438 @default.
• W2008617110 cites W2031934837 @default.
• W2008617110 cites W2039339516 @default.
• W2008617110 cites W2046745698 @default.
• W2008617110 cites W2046938649 @default.
• W2008617110 cites W2057595548 @default.
• W2008617110 cites W2058112780 @default.
• W2008617110 cites W2064956973 @default.
• W2008617110 cites W2077165978 @default.
• W2008617110 cites W2082647108 @default.
• W2008617110 cites W2105702436 @default.
• W2008617110 cites W2109825691 @default.
• W2008617110 cites W2117512155 @default.
• W2008617110 cites W2119394949 @default.
• W2008617110 cites W2124505709 @default.
• W2008617110 cites W2130441728 @default.
• W2008617110 cites W2148249666 @default.
• W2008617110 cites W2149087734 @default.
• W2008617110 cites W2151176095 @default.
• W2008617110 cites W2153207056 @default.
• W2008617110 cites W2153232301 @default.
• W2008617110 cites W2155229144 @default.
• W2008617110 cites W2157177671 @default.
• W2008617110 cites W2159616563 @default.
• W2008617110 cites W2159812729 @default.
• W2008617110 cites W2160795579 @default.
• W2008617110 cites W2164343098 @default.
• W2008617110 cites W2169404274 @default.
• W2008617110 cites W2186095724 @default.
• W2008617110 cites W2412876393 @default.
• W2008617110 cites W4231030417 @default.
• W2008617110 cites W4234673026 @default.
• W2008617110 cites W74050426 @default.
• W2008617110 cites W94004259 @default.
• W2008617110 doi "https://doi.org/10.1186/1471-2334-11-134" @default.
• W2008617110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3123567" @default.
• W2008617110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21592407" @default.
• W2008617110 hasPublicationYear "2011" @default.
• W2008617110 type Work @default.
• W2008617110 sameAs 2008617110 @default.
• W2008617110 citedByCount "168" @default.
• W2008617110 countsByYear W20086171102012 @default.
• W2008617110 countsByYear W20086171102013 @default.
• W2008617110 countsByYear W20086171102014 @default.
• W2008617110 countsByYear W20086171102015 @default.
• W2008617110 countsByYear W20086171102016 @default.
• W2008617110 countsByYear W20086171102017 @default.
• W2008617110 countsByYear W20086171102018 @default.
• W2008617110 countsByYear W20086171102019 @default.
• W2008617110 countsByYear W20086171102020 @default.
• W2008617110 countsByYear W20086171102021 @default.
• W2008617110 countsByYear W20086171102022 @default.
• W2008617110 countsByYear W20086171102023 @default.
• W2008617110 crossrefType "journal-article" @default.
• W2008617110 hasAuthorship W2008617110A5001585828 @default.
• W2008617110 hasAuthorship W2008617110A5005935743 @default.
• W2008617110 hasAuthorship W2008617110A5008177827 @default.
• W2008617110 hasAuthorship W2008617110A5029801001 @default.
• W2008617110 hasBestOaLocation W20086171101 @default.
• W2008617110 hasConcept C114851261 @default.
• W2008617110 hasConcept C120665830 @default.
• W2008617110 hasConcept C121332964 @default.
• W2008617110 hasConcept C126322002 @default.
• W2008617110 hasConcept C134164806 @default.
• W2008617110 hasConcept C159047783 @default.
• W2008617110 hasConcept C190139176 @default.
• W2008617110 hasConcept C2522874641 @default.
• W2008617110 hasConcept C2777538117 @default.
• W2008617110 hasConcept C2779134260 @default.
• W2008617110 hasConcept C2780374985 @default.
• W2008617110 hasConcept C2781442963 @default.
• W2008617110 hasConcept C2908647359 @default.
• W2008617110 hasConcept C3008058167 @default.
• W2008617110 hasConcept C524204448 @default.

• next